Lenalidomide 15mg capsules
NHS hospitals in England used £58,974,222 of indicative cost of Lenalidomide 15mg capsules in the 12 months to July 2026, about 0.2% of all hospital medicines spend. That is up 5.3% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Lenalidomide 15mg capsules: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Lenalidomide 15mg capsules most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| University Hospital Southampton Nhs Ft | £1,543,941 |
| Western Sussex Hospitals Nhs Found Trust | £1,532,034 |
| South Tyneside And Sunderland Nhs Ft | £1,450,953 |
| University College London Foundation Tr | £1,448,800 |
| Southend Univ Hosp Nhs Foundation Trust | £1,392,930 |
| Colchester Hospital University Nhs Ft | £1,375,224 |
| Worcestershire Acute Hpls Nhs Trust | £1,158,192 |
| Univ Hpl B/Ham Nhs Foundation Trust | £1,140,237 |
| The Clatterbridge Cancer Centre Nhs Ft | £1,056,321 |
| Oxford University Hospitals Nhs Ft | £1,020,222 |
The primary-care picture
Lenalidomide is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Lenalidomide medicine page.